Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Pediatric Acute Megakaryoblastic Leukemia"'
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e301-e308
Background Acute megakaryoblastic leukemia (AMKL) is a biologically heterogeneous subtype of acute myeloid leukemia that originates from megakaryocytes. Patients with AMKL with non-Down syndrome (DS) had a poorer prognosis. However, clear prognostic
Publikováno v:
Expert Review of Hematology. 12:285-293
Acute megakaryoblastic leukemia (AMegL) is a rare hematological neoplasm most often diagnosed in children and is commonly associated with Down's syndrome (DS). Although AMegLs are specifically characterized and typically diagnosed by megakaryoblastic
Autor:
Oussama Abla, Samuele Renzi, Adam Shlien, Scott Davidson, Karin Langenberg-Ververgaert, David Malkin, Mary Shago, Anita Villani, Fabio Fuligni, Winnie Lo, Mohamed Abdelhaleem
Publikováno v:
Pediatric Blood & Cancer. 68
Background: Acute megakaryoblastic leukemia (AMKL) is a biologically heterogeneous subtype of acute myeloid leukemia (AML) that originates from megakaryocytes. Despite improvements in the accuracy of diagnosing AMKL as well as increased amount of dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2ee97010079e665d6d27625d1bfa112
https://doi.org/10.21203/rs.3.rs-30984/v1
https://doi.org/10.21203/rs.3.rs-30984/v1
Publikováno v:
Case Reports in Pediatrics
Case Reports in Pediatrics, Vol 2020 (2020)
Case Reports in Pediatrics, Vol 2020 (2020)
Pediatric acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML) that may be divided into two subgroups: (1) Down syndrome- (DS-) related AMKL which generally has a favorable prognosis and (2) non-DS-related AMKL whi
Publikováno v:
Trends in Cancer. 3:631-642
Pediatric leukemia presents specific clinical and genetic features from adult leukemia but the underpinning mechanisms of transformation are still unclear. Acute megakaryoblastic leukemia (AMKL) is the malignant accumulation of progenitors of the meg
Publikováno v:
Klinische Pädiatrie.
Publikováno v:
Klinische Pädiatrie.
Autor:
Arnaud Petit, Anne-Charlotte Teyssier, Stéphane Ducassou, Guy Leverger, Odile Fenneteau, André Baruchel, Wendy Cuccuini, Paola Ballerini, Christine Ragu, Marlène Pasquet, Claude Preudhomme, Nicolas Sirvent, Hélène Lapillonne, Thomas Mercher
Publikováno v:
Pediatric Hematology-Oncology
Pediatric Hematology-Oncology, Taylor & Francis, 2017, 34 (8), pp.425--427. ⟨10.1080/08880018.2017.1414905⟩
Pediatric Hematology-Oncology, 2017, 34 (8), pp.425--427. ⟨10.1080/08880018.2017.1414905⟩
Pediatric Hematology-Oncology, Taylor & Francis, 2017, 34 (8), pp.425--427. ⟨10.1080/08880018.2017.1414905⟩
Pediatric Hematology-Oncology, 2017, 34 (8), pp.425--427. ⟨10.1080/08880018.2017.1414905⟩
International audience; We report the outcome of 27 children with de novo acute megakaryoblastic leukemia (AMKL) (excluding Down syndrome) enrolled in the French multicenter prospective study ELAM02 (2005-2011). There was no difference in gender, ini
Autor:
Iwona Pawlikowska, Stan Pounds, Tanja A. Gruber, Zhifa Liu, Gang Wu, Michael N. Edmonson, Jinghui Zhang
Publikováno v:
Bioinformatics. 30:1400-1408
Summary: Several outlier and subgroup identification statistics (OASIS) have been proposed to discover transcriptomic features with outliers or multiple modes in expression that are indicative of distinct biological processes or subgroups. Here, we b